Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different Beta-Blockers in STEMI Patients Undergoing Primary PCI
NCT04221919Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of carvedilol, bisoprolol and metoprolol in ST-segment elevation myocardial infarction (STEMI) (4 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Change in Left Ventricular End Diastolic Volume from baseline and Major adverse cardiovascular events. Status: unknown.
02
Drugs
carvedilolbisoprololmetoprolol
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT04221919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221919.